From Sample to Insight

QIAGEN reports full results for second quarter and first half of 2020

QIAGEN announces publication of Supplemental Reasoned Position Statement for proposed acquisition by Thermo Fisher

Thermo Fisher Scientific and QIAGEN N.V. Agree on Amended Terms to Acquisition Agreement

QIAGEN provides update on Q2 2020 results, announces strong outlook for Q3 and FY 2020, and 2021 perspectives in light of coronavirus pandemic

QIAGEN announces preliminary results for Q2 2020

QIAGEN shareholders approve all agenda items related to acquisition by Thermo Fisher Scientific at Annual General Meeting

QIAGEN provides information on potential capital gain from its minority investment in ArcherDX

QIAGEN announces plans to release preliminary Q2 2020 results

QIAGEN builds on leading position in Precision Medicine with novel solutions in oncology

QIAGEN announces publication of Reasoned Position Statement for proposed acquisition by Thermo Fisher and date for Annual General Meeting